Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Net Income (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Net Income for 15 consecutive years, with -$31.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Income fell 132615.77% year-over-year to -$31.2 million, compared with a TTM value of -$38.1 million through Sep 2025, down 579.11%, and an annual FY2024 reading of -$9.8 million, down 121.22% over the prior year.
  • Net Income was -$31.2 million for Q3 2025 at Sanara MedTech, down from -$1.8 million in the prior quarter.
  • Across five years, Net Income topped out at $756914.0 in Q2 2022 and bottomed at -$31.2 million in Q3 2025.
  • Average Net Income over 5 years is -$3.4 million, with a median of -$1.8 million recorded in 2025.
  • The sharpest move saw Net Income skyrocketed 173.76% in 2022, then crashed 132615.77% in 2025.
  • Year by year, Net Income stood at -$3.4 million in 2021, then fell by 23.32% to -$4.2 million in 2022, then surged by 93.76% to -$262444.0 in 2023, then plummeted by 534.05% to -$1.7 million in 2024, then plummeted by 1777.78% to -$31.2 million in 2025.
  • Business Quant data shows Net Income for SMTI at -$31.2 million in Q3 2025, -$1.8 million in Q2 2025, and -$3.4 million in Q1 2025.